S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.21
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.51
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
CAI · Caris Life Sciences, Inc.
NASDAQ NMS - GLOBAL MARKET - Real Time Price • USD
Caris Life Sciences Inc (CAI)
NASDAQ NMS - GLOBAL MARKET
Biotechnology
$32.34
+1.21
(+3.89%)
● At close: October 21 at 4:00:00 PM EDT
$32.09
-0.26
(-0.79%)
After-Hours:
5:39:00 PM EDT
DAY'S RANGE
$32.34
$30.98
$32.71
52-WEEK RANGE
$32.34
$14.19
$33.13
What's happening
- CAI is up 3.89% today, trading at $32.34. — Live quote
- Volume today (163,902) is well below its 3-month average of 4,461,300. (Finnhub fundamentals)
- Reports earnings on 2026-11-04, 14 days away. (Finnhub earnings calendar)
- Last quarter's EPS missed estimates: $0.00 actual vs. $0.01 estimated (-100.0%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 6
Buy 6
Hold 4
Sell 0
Strong sell 0
Aggregate ratings for 2026-10-01 (16 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
CAI
+15.31%
vs S&P 500
+2.53%
1-YEAR RETURN
CAI
-1.24%
vs S&P 500
-15.80%
6-MONTH RETURN
CAI
+52.50%
3-MONTH RETURN
CAI
+97.78%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$0.00
Est. $0.01
MISS -100.0%
2026-04-26 (Q1 2026)
$0.00
Est. $-0.02
BEAT +100.0%
2026-01-26 (Q4 2025)
$0.28
Est. $0.03
BEAT +777.7%
2025-10-26 (Q3 2025)
$0.08
Est. $-0.21
BEAT +138.7%
Valuation Measures & Ratios
Enterprise Value4$8.49B
Forward P/E599.47
PEG Ratio6—
Price / Sales (TTM1)8.88
Price / Book78.51
EV4 / Revenue8.58
EV4 / EBITDA57.85
Profit Margin10.62%
Operating Margin12.74%
Return on Equity (ROE8)18.77%
Return on Assets (ROA9)9.34%
Avg Volume (3M)4,461,300
Quarterly history (4 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 |
|---|---|---|---|---|
| Market cap | — | — | $9.17B | $241.0M |
| P/E | — | — | -42.12 | -0.78 |
| Price/Sales | — | — | 14.78 | 0.48 |
| Price/Book | — | — | 19.18 | 0.53 |
| EV/Revenue | — | — | 14.17 | -0.21 |
| EV/EBITDA | — | — | -116.83 | — |
| ROE | — | — | -45.52% | -68.07% |
| ROA | — | — | -22.12% | -32.28% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short13,891,975
Change from Prior Settlement+4.20%
% of Float—
Days to Cover (Short Ratio)2.48
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 45.4% on the provider's reported measure. Finnhub fundamentals ↗
- Net profit margin is 10.6%. Finnhub fundamentals ↗
Potential concerns
- Trailing 52-week price return is -1.2%. Finnhub market metrics ↗
- Trailing P/E is 83.6, a high price relative to reported earnings. Finnhub fundamentals ↗
- Latest SEC filing is Form 4, filed 2026-09-23; review it for current changes and risks. SEC EDGAR ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on CAI
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 |
|---|---|---|---|---|---|---|---|
| Revenue | $263.7M | $216.2M | $216.8M | $181.4M | $120.9M | $101.6M | $100.0M |
| Operating income | $26.9M | $5.3M | $32.6M | -$18.0M | -$58.0M | -$60.8M | -$67.0M |
| Net income | -$637.0K | -$510.0K | $24.3M | -$71.8M | -$102.6M | -$67.7M | -$66.2M |
| EPS (diluted) | $0.00 | $0.00 | $0.08 | $-7.97 | $-3.57 | $-2.59 | $-2.54 |
| EPS (basic) | $0.00 | $0.00 | $0.09 | $-7.97 | $-3.57 | $-2.59 | $-2.54 |
| Operating margin | $10 | $2 | $15 | -$10 | -$48 | -$60 | -$67 |
| Net margin | -$0 | -$0 | $11 | -$40 | -$85 | -$67 | -$66 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $1.23B | $1.16B | $1.13B | $984.6M | $955.1M | — | $343.7M | — |
| Total liabilities | $637.9M | $568.9M | $548.4M | $506.2M | $502.2M | — | $620.9M | — |
| Stockholders' equity | $591.7M | $593.5M | $577.3M | $478.4M | $452.9M | -$2.60B | -$2.50B | -$2.44B |
| Total current assets | $1.06B | $1.01B | $997.8M | $854.2M | $833.3M | — | $215.7M | — |
| Total current liabilities | $191.4M | $143.9M | $127.1M | $86.0M | $90.2M | — | $165.4M | — |
| Cash & equivalents | — | $819.9M | $796.3M | $753.2M | $718.9M | $31.2M | $64.0M | — |
| Marketable securities (current) | $102.2M | $2.3M | $2.3M | $2.3M | $2.2M | — | $2.2M | — |
| Accounts receivable | $116.9M | $90.5M | $112.1M | $26.7M | $50.9M | — | $88.2M | — |
| Other current assets | $5.1M | $4.3M | $2.4M | $2.6M | $2.5M | — | $6.7M | — |
| Property, plant & equipment | $95.7M | $82.7M | $63.2M | $64.0M | $61.3M | — | $67.8M | — |
| Goodwill | $19.3M | $19.3M | $19.3M | $19.3M | $19.3M | — | $19.3M | — |
| Other non-current assets | $56.7M | $46.2M | $45.3M | $47.0M | $41.1M | — | $40.8M | — |
| Accounts payable | $86.0M | $69.8M | $39.2M | $29.0M | $28.7M | — | $27.8M | — |
| Accrued liabilities | $105.3M | $73.9M | $87.8M | $56.9M | $61.4M | — | $77.5M | — |
| Deferred revenue (current) | $20.5M | $25.0M | $24.5M | $2.8M | $5.3M | — | $7.5M | — |
| Short-term debt | $178.0K | $173.0K | $169.0K | $164.0K | $95.0K | — | $60.1M | — |
| Long-term debt | $393.0M | $381.4M | $378.8M | $376.3M | $373.6M | — | $319.4M | — |
| Other non-current liabilities | $53.5M | $43.6M | $42.4M | $43.9M | $38.4M | — | $44.4M | — |
| Common stock & paid-in capital | $283.0K | $284.0K | $283.0K | $283.0K | $282.0K | — | $38.0K | — |
| Retained earnings | -$2.55B | -$2.55B | -$2.55B | -$2.63B | -$2.66B | — | -$2.47B | — |
| Accumulated other comprehensive income (loss) | $529.0K | $893.0K | $936.0K | $748.0K | $669.0K | — | $210.0K | — |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $28.5M | $32.9M | $44.8M | $62.4M | $7.3M | -$31.3M | -$38.9M | -$69.4M |
| Investing cash flow | -$122.2M | -$10.3M | -$5.1M | -$7.1M | -$1.4M | -$2.7M | -$2.3M | -$1.8M |
| Financing cash flow | -$36.9M | $824.0K | $3.4M | -$21.1M | $681.4M | $1.3M | $226.0K | $87.0K |
| Free cash flow | — | $22.5M | $39.7M | $55.3M | $5.9M | -$34.0M | -$41.2M | -$71.3M |
| Capital expenditures | — | $10.3M | $5.1M | $7.1M | $1.4M | $2.7M | $2.3M | $1.8M |
| Depreciation & amortization | $6.5M | $5.1M | $15.6M | $4.9M | $6.4M | $7.0M | $48.9M | $10.5M |
| Share-based compensation | $22.2M | $15.9M | $13.4M | $13.7M | $28.3M | $14.7M | $5.0M | $4.7M |
| Change in accounts receivable | $26.4M | -$21.6M | $91.0M | -$24.2M | -$29.1M | -$7.9M | $18.8M | -$1.9M |
| Change in accounts payable | $23.3M | $16.4M | $12.2M | $729.0K | -$186.0K | -$1.7M | -$5.3M | $2.4M |
| Purchases of investments | $102.0M | — | $0 | — | $0 | — | $0 | — |
| Sales/maturities of investments | $1.9M | — | — | — | $0 | — | — | — |
| Share repurchases | $21.4M | $0 | $91.0K | $0 | $0 | $22.0K | $0 | $0 |
| Tax withholding on stock comp | $5.3M | $56.0K | $333.0K | $16.6M | $1.7M | $0 | $0 | $0 |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 |
|---|---|---|---|
| Revenue | $812.0M | $412.3M | $306.1M |
| Operating income | $45.1M | -$257.1M | -$319.6M |
| Net income | -$68.1M | -$281.9M | -$341.4M |
| EPS (diluted) | $-3.22 | $-10.66 | $-13.24 |
| EPS (basic) | $-3.22 | $-10.66 | $-13.24 |
| Operating margin | $6 | -$62 | -$104 |
| Net margin | -$8 | -$68 | -$112 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 |
|---|---|---|---|---|
| Total assets | $1.13B | $343.7M | — | — |
| Total liabilities | $548.4M | $620.9M | — | — |
| Stockholders' equity | $577.3M | -$2.50B | -$2.14B | -$1.70B |
| Total current assets | $997.8M | $215.7M | — | — |
| Total current liabilities | $127.1M | $165.4M | — | — |
| Cash & equivalents | $796.3M | $64.0M | — | — |
| Marketable securities (current) | $2.3M | $2.2M | — | — |
| Accounts receivable | $112.1M | $88.2M | — | — |
| Other current assets | $2.4M | $6.7M | — | — |
| Property, plant & equipment | $63.2M | $67.8M | — | — |
| Goodwill | $19.3M | $19.3M | — | — |
| Other non-current assets | $45.3M | $40.8M | — | — |
| Accounts payable | $39.2M | $27.8M | — | — |
| Accrued liabilities | $87.8M | $77.5M | — | — |
| Deferred revenue (current) | $24.5M | $7.5M | — | — |
| Short-term debt | $169.0K | $60.1M | — | — |
| Long-term debt | $378.8M | $319.4M | — | — |
| Other non-current liabilities | $42.4M | $44.4M | — | — |
| Common stock & paid-in capital | $283.0K | $38.0K | — | — |
| Retained earnings | -$2.55B | -$2.47B | — | — |
| Accumulated other comprehensive income (loss) | $936.0K | $210.0K | — | — |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 |
|---|---|---|---|
| Operating cash flow | $83.2M | -$245.2M | -$276.1M |
| Investing cash flow | -$16.3M | $52.9M | $214.8M |
| Financing cash flow | $665.0M | $200.3M | $10.1M |
| Free cash flow | $66.9M | -$253.6M | -$298.4M |
| Capital expenditures | $16.3M | $8.4M | $22.3M |
| Depreciation & amortization | $22.6M | $48.9M | $49.0M |
| Share-based compensation | $70.0M | $18.6M | $15.2M |
| Change in accounts receivable | $29.8M | $33.8M | $15.1M |
| Change in accounts payable | $11.0M | -$226.0K | $7.2M |
| Purchases of investments | $0 | $0 | $63.4M |
| Share repurchases | $113.0K | $0 | $0 |
| Tax withholding on stock comp | $18.6M | $0 | $0 |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding CAI as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Source: Business Quant SEC Form 13F · report period 2026-06-30 · 30 filers
Held by These Filers45.8%
Shares Outstanding282,888,610
| Filer | Shares | Value | % Out | Qtr Change | Filed |
|---|---|---|---|---|---|
| FMR LLC | 30,923,878 | $551.1M | 10.93% | +0.4% | 2026-08-13 |
| J. H. Whitney Equity Partners VI, LLC | 11,256,615 | $200.6M | 3.98% | -38.3% | 2026-08-12 |
| COATUE MANAGEMENT LLC | 9,819,992 | $175.0M | 3.47% | +0.0% | 2026-08-14 |
| BRAIDWELL LP | 8,256,032 | $147.1M | 2.92% | +3.1% | 2026-08-14 |
| PointState Capital LP | 6,828,835 | $121.7M | 2.41% | -7.2% | 2026-08-14 |
| Jpmorgan Chase & Co | 6,558,514 | $120.2M | 2.32% | +89.5% | 2026-08-12 |
| BlackRock, Inc. | 5,536,798 | $98.7M | 1.96% | +14.0% | 2026-08-07 |
| T. Rowe Price Investment Management, Inc. | 5,079,141 | $90.5K | 1.80% | -9.1% | 2026-08-14 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4,844,431 | $86.3M | 1.71% | +28.9% | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4,280,238 | $76.3M | 1.51% | +28.6% | 2026-06-30 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 3,958,531 | $70.5M | 1.40% | +72.9% | 2026-08-13 |
| Neuberger Berman Group LLC | 3,590,963 | $64.0M | 1.27% | +0.0% | 2026-08-13 |
| ORBIMED ADVISORS LLC | 2,806,811 | $50.0M | 0.99% | +0.0% | 2026-08-14 |
| BNP PARIBAS FINANCIAL MARKETS | 2,370,268 | $42.2M | 0.84% | +46.8% | 2026-08-10 |
| MILLENNIUM MANAGEMENT LLC | 2,202,647 | $39.3M | 0.78% | +44.2% | 2026-08-14 |
| MAK CAPITAL ONE LLC | 1,937,229 | $34.5M | 0.68% | +0.0% | 2026-08-14 |
| Morgan Stanley | 1,935,531 | $34.5M | 0.68% | +79.3% | 2026-08-11 |
| Duquesne Family Office LLC | 1,894,450 | $33.8K | 0.67% | +0.0% | 2026-08-14 |
| Clearbridge Investments, LLC | 1,595,877 | $28.4M | 0.56% | +2.8% | 2026-08-10 |
| FIL Ltd | 1,548,918 | $27.6M | 0.55% | +0.2% | 2026-08-13 |
| UBS Group AG | 1,423,371 | $25.4M | 0.50% | -48.2% | 2026-08-13 |
| HRT FINANCIAL LP | 1,418,392 | $25.3K | 0.50% | +0.0% | 2026-08-14 |
| CANADA PENSION PLAN INVESTMENT BOARD | 1,374,952 | $24.5M | 0.49% | +3.9% | 2026-08-14 |
| Amundi | 1,218,364 | $21.7M | 0.43% | +5709.5% | 2026-08-11 |
| State Street Corp | 1,217,548 | $21.7M | 0.43% | +23.6% | 2026-08-07 |
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-03-06 to 2026-09-22
Recent transactions
- Insiders have net sold 905,662 shares over the last 182 days, across 2 purchases and 5 sales.
- Most recent: Denton John Russel (See Remarks) — Open market sale of 7,500 shares on 2026-09-22.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)99,050 sh(2 txns)
Sales (open market)1,004,712 sh(5 txns)
Net Shares-905,662
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Denton John Russel | See Remarks | Open market sale | 2026-09-22 | 7,500 |
| Brille Brian J | See Remarks | Option exercise | 2026-09-17 | 400,000 |
| Spetzler David Baxley | President | Option exercise | 2026-09-04 | 250,000 |
| CASTLEMAN PETER M | Director | Grant / award | 2026-08-14 | 13,192 |
| PHILLIPS T DANNY | Director | Grant / award | 2026-08-14 | 13,192 |
| Minor Lloyd | Director | Grant / award | 2026-08-14 | 13,192 |
| Gilliam Joseph E | Director | Grant / award | 2026-08-14 | 13,192 |
| Fredrickson David Paul | Director | Grant / award | 2026-08-14 | 13,192 |
| Vacirca Jeff L | Director | Grant / award | 2026-08-14 | 13,192 |
| JOHANSEN LAURA I | Director | Grant / award | 2026-08-14 | 13,192 |
| HALBERT JON | Director | Grant / award | 2026-08-14 | 13,192 |
| POSTE GEORGE | Director | Grant / award | 2026-05-29 | 1,600 |
| Knowles Jonathan Kenneth Charles | Director | Grant / award | 2026-05-29 | 1,600 |
| Power Luke Thomas | See Remarks | Tax withholding | 2026-05-15 | 9,771 |
| HALBERT DAVID D | See Remarks | Tax withholding | 2026-05-15 | 40,712 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-22 | Denton John Russel | See Remarks | Open market sale | 7,500 | $31.82 |
| 2026-09-17 | Brille Brian J | See Remarks | Option exercise | 400,000 | $2.44 |
| 2026-09-17 | Brille Brian J | See Remarks | Open market sale | 400,000 | $30.33 |
| 2026-09-04 | Spetzler David Baxley | President | Option exercise | 250,000 | $2.44 |
| 2026-09-04 | Spetzler David Baxley | President | Open market sale | 119,212 | $24.76 |
| 2026-09-03 | Spetzler David Baxley | President | Option exercise | 1,000,000 | $2.44 |
| 2026-09-03 | Spetzler David Baxley | President | Open market sale | 393,100 | $24.76 |
| 2026-09-03 | Spetzler David Baxley | President | Open market sale | 84,900 | $25.32 |
| 2026-08-14 | CASTLEMAN PETER M | Director | Grant / award | 13,192 | $0.00 |
| 2026-08-14 | PHILLIPS T DANNY | Director | Grant / award | 13,192 | $0.00 |
| 2026-08-14 | Minor Lloyd | Director | Grant / award | 13,192 | $0.00 |
| 2026-08-14 | Gilliam Joseph E | Director | Grant / award | 13,192 | $0.00 |
| 2026-08-14 | Fredrickson David Paul | Director | Grant / award | 13,192 | $0.00 |
| 2026-08-14 | Vacirca Jeff L | Director | Grant / award | 13,192 | $0.00 |
| 2026-08-14 | JOHANSEN LAURA I | Director | Grant / award | 13,192 | $0.00 |
| 2026-08-14 | HALBERT JON | Director | Grant / award | 13,192 | $0.00 |
| 2026-05-29 | POSTE GEORGE | Director | Grant / award | 1,600 | $15.62 |
| 2026-05-29 | Knowles Jonathan Kenneth Charles | Director | Grant / award | 1,600 | $15.62 |
| 2026-05-15 | HALBERT JON | Director | Open market purchase | 68,000 | $14.56 |
| 2026-05-15 | Denton John Russel | See Remarks | Tax withholding | 6,047 | $15.25 |
| 2026-05-15 | Power Luke Thomas | See Remarks | Tax withholding | 9,771 | $15.25 |
| 2026-05-15 | Spetzler David Baxley | President | Tax withholding | 13,856 | $15.25 |
| 2026-05-15 | Brille Brian J | See Remarks | Tax withholding | 13,987 | $15.25 |
| 2026-05-15 | HALBERT DAVID D | See Remarks | Tax withholding | 40,712 | $15.25 |
| 2026-05-11 | Vacirca Jeff L | Director | Open market purchase | 31,050 | $16.15 |
| 2026-03-06 | Power Luke Thomas | See Remarks | Grant / award | 63,971 | $0.00 |
| 2026-03-06 | Denton John Russel | See Remarks | Grant / award | 63,971 | $0.00 |
| 2026-03-06 | Spetzler David Baxley | President | Grant / award | 83,162 | $0.00 |
| 2026-03-06 | Brille Brian J | See Remarks | Grant / award | 83,162 | $0.00 |
| 2026-03-06 | HALBERT DAVID D | See Remarks | Grant / award | 320,112 | $0.00 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-21 23:40 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-09-23 | 4 | 2026-09-22 | View on SEC.gov → |
| 2026-09-17 | 4 | 2026-09-17 | View on SEC.gov → |
| 2026-09-14 | 8-K | 2026-09-14 | View on SEC.gov → |
| 2026-09-04 | 4 | 2026-09-03 | View on SEC.gov → |
| 2026-08-14 | 4 | 2026-08-14 | View on SEC.gov → |
| 2026-08-14 | 4 | 2026-08-14 | View on SEC.gov → |
| 2026-08-14 | 4 | 2026-08-14 | View on SEC.gov → |
| 2026-08-14 | 4 | 2026-08-14 | View on SEC.gov → |
| 2026-08-14 | 4 | 2026-08-14 | View on SEC.gov → |
| 2026-08-14 | 4 | 2026-08-14 | View on SEC.gov → |
| 2026-08-14 | 4 | 2026-08-14 | View on SEC.gov → |
| 2026-08-14 | 4 | 2026-08-14 | View on SEC.gov → |
Recent news
Headlines about CAI (Caris Life Sciences, Inc.). Links open the publisher — we don’t host full articles.
-
Lao Cai province has established the Xuan Ai Industrial Cluster, covering 75 hectares with an investment of over 815 billion VND.
Vietnam.vn · 2026-10-21 -
CAI270416C00030000 Interactive Stock Chart | CAI Apr 2027 30.000 call Stock
Yahoo Finance · 2026-10-20 -
ETFs Investing in Caris Life Sciences, Inc. Stocks
TradingView · 2026-10-20 -
Lao Cai Power Company held a meeting to commemorate October 20th.
Vietnam.vn · 2026-10-20 -
Caris Life Sciences, Inc. (CAI) stock price, news, quote and history
Yahoo Finance Singapore · 2026-10-20 -
Caris Life Sciences Inc. (CAI) Stock Price | Live Quotes & Charts | NASDAQ
Timothy Sykes · 2026-10-19 -
Caris Life Sciences, Inc. (CAI) Stock Price, News, Quote & History
Yahoo! Finance Canada · 2026-10-19 -
CAI Nov 2026 30.000 put (CAI261120P00030000) Interactive Stock Chart
Yahoo! Finance Canada · 2026-10-19
No headlines in this category right now — try “All”.